Get started
BEIJING KAWIN TECHNOLOGY SHARE-HOLDBEIJING KAWIN TECHNOLOGY SHARE-HOLDBEIJING KAWIN TECHNOLOGY SHARE-HOLD

BEIJING KAWIN TECHNOLOGY SHARE-HOLD

No trades
See on Supercharts
Overview
Financials
News Discussions Technicals Forecast Seasonals

688687 fundamentals

Key facts

Market capitalization—
Dividend yield (indicated)—
Price to earnings Ratio (TTM)—
Basic EPS (TTM)—
Founded—
Employees (FY)—
CEO—
Website—
About

Beijing Kawin Technology Share-Holding Co., Ltd. research, development, production and sales of drugs in the field of viral diseases. Its products include compound glycyrrhizin capsules, vaginal effervescent tablets, omeprazole sodium for injection, liraglutide, nivolumab, and filgrastim. The company was founded on August 20, 2008 and is headquartered in Beijing, China.

Valuation

Fundamental metrics to determine fair value of the stock

Summary
No data available
There's currently no market capitalization, revenue or net income data to show.
Valuation ratios

Growth and Profitability

Company’s recent performance and margins

Dividends

Dividend yield, history and sustainability

No dividends
688687 has never paid dividends and has no current plans to do so.

Financial health

Financial position and solvency of the company